| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-08 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.33 | 7e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |